FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
RICE II PHILIP M
  2. Issuer Name and Ticker or Trading Symbol
Zivo Bioscience, Inc. [ZIVO]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
(Last)
(First)
(Middle)
29139 NORTHWESTERN HWY SUITE 477
3. Date of Earliest Transaction (Month/Day/Year)
01/04/2013
(Street)

SOUTHFIELD, MI 48034-1006
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Purchase Warrant $ 0.12 01/04/2013   A   50,000   01/04/2013 01/04/2016 Common Stock 50,000 (2) 0 (1) D  
Common Stock Purchase Warrant $ 0.25 04/01/2013   A   50,000   04/01/2013 04/01/2018 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.25 04/30/2013   A   557,000   04/30/2013 04/30/2018 Common Stock 557,000 (2) 557,000 D  
Common Stock Purchase Warrant $ 0.25 08/10/2013   A   50,000   08/10/2013 08/10/2018 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.25 11/18/2013   A   50,000   11/18/2013 11/18/2018 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.38 01/04/2014   A   50,000   01/04/2014 01/04/2017 Common Stock 50,000 (2) 0 (1) D  
Common Stock Purchase Warrant $ 0.17 03/31/2014   A   50,000   03/31/2014 03/31/2019 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.19 05/14/2014   A   50,000   05/14/2014 05/14/2019 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.14 08/14/2014   A   50,000   08/14/2014 08/14/2019 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.09 11/14/2014   A   50,000   11/14/2014 11/14/2019 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.085 04/06/2015   A   50,000   04/06/2015 04/06/2020 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.088 05/13/2015   A   50,000   05/13/2015 05/13/2020 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.12 08/13/2015   A   50,000   08/13/2015 08/13/2020 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.10 09/10/2015   A   250,000   09/10/2015 09/10/2020 Common Stock 250,000 (2) 250,000 D  
Common Stock Purchase Warrant $ 0.08 11/13/2015   A   50,000   11/13/2015 08/13/2020 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.08 03/29/2016   A   50,000   03/29/2016 03/29/2021 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.08 05/13/2016   A   50,000   05/13/2016 05/13/2021 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.08 08/12/2016   A   50,000   08/12/2016 08/12/2021 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.05 09/10/2016   A   250,000   09/10/2016 09/10/2021 Common Stock 250,000 (2) 250,000 D  
Common Stock Purchase Warrant $ 0.08 11/14/2016   A   50,000   11/14/2016 11/14/2021 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.08 03/31/2017   A   50,000   03/31/2017 03/31/2022 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.09 05/12/2017   A   50,000   05/12/2017 05/12/2022 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.06 08/13/2017   A   50,000   08/13/2017 08/13/2022 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.07 09/11/2017   A   500,000   09/11/2017 09/11/2022 Common Stock 500,000 (2) 500,000 D  
Common Stock Purchase Warrant $ 0.07 10/19/2017   A   50,000   10/19/2017 10/19/2022 Common Stock 50,000 (2) 50,000 D  
Common Stock Purchase Warrant $ 0.08 11/08/2017   A   6,000,000   11/08/2017 11/08/2022 Common Stock 6,000,000 (2) 6,000,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
RICE II PHILIP M
29139 NORTHWESTERN HWY SUITE 477
SOUTHFIELD, MI 48034-1006
  X     Chief Financial Officer  

Signatures

 /s/ Philip M. Rice II   02/09/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These warrants have expired.
(2) The warrants were issued to the reporting person as compensation for acting as a director.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.